单次基因编辑剂量可以降低罕见遗传疾病中的胆固醇. Single gene-editing dose lowers cholesterol in rare genetic condition.

基因编辑的突破性治疗已经显示出有希望的结果, A groundbreaking gene-editing treatment has shown promising results in lowering cholesterol with a single dose for patients with a rare genetic condition. 一位多次心脏病发作的参与者发现, 经过一次CRISPR治疗后, 调节脂质基因被禁用之后, 他的LDL胆固醇降低了近一半. A participant who had multiple heart attacks saw his LDL cholesterol drop by nearly half after a one-time CRISPR therapy disabled a gene regulating lipids. 专家们认为这种方法最终可以为人们提供终身的预防心脏病. While still in early testing, experts believe this approach could eventually offer lifelong protection against heart disease.